[1]吴中兴,吴连清.双芪参滴丸联合尼可地尔治疗缺血性心绞痛41例临床观察[J].西部中医药,2022,35(04):114-116.[doi:10.12174/j.issn.2096-9600.2022.04.26]
 WU Zhongxing,WU Lianqing.Clinical Effects of Shuangqishen Dripping Pills and Nicorandil in the Treatment of 41 Cases of Ischemic Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2022,35(04):114-116.[doi:10.12174/j.issn.2096-9600.2022.04.26]
点击复制

双芪参滴丸联合尼可地尔治疗缺血性心绞痛41例临床观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年04期
页码:
114-116
栏目:
临证经验
出版日期:
2022-04-15

文章信息/Info

Title:
Clinical Effects of Shuangqishen Dripping Pills and Nicorandil in the Treatment of 41 Cases of Ischemic Angina Pectoris
作者:
吴中兴 吴连清
资阳市中医医院,四川 资阳 641300
Author(s):
WU Zhongxing WU Lianqing
Ziyang City Hospital of Traditional Chinese Medicine, Ziyang 641300, China
关键词:
心绞痛缺血性双芪参滴丸尼可地尔肌酸激酶同工酶MB高敏C反应蛋白N末端B型利钠肽原
Keywords:
ischemic angina pectorisdripping pillsnicorandilCKMBhs-CRPNT-ProBNP
分类号:
R972.3
DOI:
10.12174/j.issn.2096-9600.2022.04.26
文献标志码:
B
摘要:
目的探讨双芪参滴丸联合尼可地尔对缺血性心绞痛患者的临床疗效及对血清肌酸激酶同工酶MB(creatine kinase MB,CKMB)、高敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)、N末端B型钠尿肽原(N-terminal pro-B type natriuretic peptide,NT-ProBNP)水平的影响。 方法选取确诊为缺血性心绞痛患者82例,随机分为观察组和对照组,每组41例。对照组应用尼可地尔治疗,观察组应用双芪参滴丸联合尼可地尔治疗。比较两组血清CKMB、hs-CRP和NT-ProBNP水平,西雅图量表疗效积分,心绞痛疗效。 结果治疗后两组血清CKMB、hs-CRP、NT-ProBNP水平均低于治疗前(P<0.05),且观察组低于对照组(P<0.05);治疗后两组西雅图量表各维度疗效评分均高于治疗前(P<0.05),且观察组高于对照组(P<0.05);观察组心绞痛有效率[90.3%(37/41)]高于对照组[80.5%(33/41)](P<0.05)。 结论芪参滴丸联合尼可地尔治疗缺血性心绞痛,可提高临床疗效,其治疗机制可能与改善患者CKMB、hs-CRP和NT-ProBNP水平有关。
Abstract:
ObjectiveTo investigate clinical effect of Shuangqishen dripping pills combined with nicorandil in the treatment of ischemic angina pectoris and its influence on the levels of CKMB, hs-CRP and NT-ProBNP. MethodsAll 82 patients with confirmed ischemic angina pectoris were chosen, and randomized into the observa-tion group and the control group, with 41 cases in each group. The control group took nicorandil orally, and the observation group was treated by Shuangqishen dripping pills and nicorandil. To compare the levels of CKMB, hs-CRP and NT-ProBNP, the scores of Seattle angina questionnaire (SAQ) and clinical effects of angina pectoris. ResultsAfter the treatment, the levels of CKMB, hs-CRP and NT-ProBNP in both groups were lower than these before treating (P<0.05), and the observation group was lower than the control group (P<0.05); after the treatment, efficacy scores of the dimensions of SAQ in both groups were higher than these before treating (P<0.05), and the observation group was higher than the control group (P<0.05); AP effective rate of the observation group was [90.3%(37/41)], higher than [80.5%(33/41)] of the control group (P<0.05). ConclusionShuangqishen dripping pills combined with nicorandil in the treatment of ischemic angina pectoris could raise clinical therapeutic effects, and its mechanism might be related to improving the levels of CKMB, hs-CRP and NT-ProBNP.

相似文献/References:

[1]赵军,马晓东,贾孟辉,等.“失合刺治丸”治疗缺血性脑卒中后遗症30例[J].西部中医药,2011,24(11):20.
[2]程善廷,王嘉锋,杨小兰,等.熄风振颓煎对缺血性中风二级预防的研究*[J].西部中医药,2013,26(03):71.
 CHENG Shanting,WANG Jiafeng,YANG Xiaolan,et al.Study on XiFeng ZhenTuiJian in Secondary Prevention of Ischemic Stroke[J].Western Journal of Traditional Chinese Medicine,2013,26(04):71.
[3]王鸿燕.丹参酮注射液治疗老年不稳定型心绞痛(心血瘀阻证)50例临床观察[J].西部中医药,2013,26(05):5.
 WANG Hongyan.Observation on DanShenTong Injection in Treating 50 Cases of Senile Unstable Angina Pectoris of Heart Blood Stagnation-obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):5.
[4]范宗鹏,吴玉姣.穴位埋线联合中药治疗不稳定型心绞痛临床观察[J].西部中医药,2013,26(04):90.
 FAN Zongpeng,WU Yujiao.Clinical Observation on Treatment of Unstable Angina Pectoris with Catgut Embedding at Acupoints and Herbs[J].Western Journal of Traditional Chinese Medicine,2013,26(04):90.
[5]王芳芳.益气活血方对UAP易损斑块相关血清学指标MMP—9、sCD40L、sVCAM—1水平表达的影响[J].西部中医药,2012,25(08):1.
 WANG Fang-fang.Influence of YiQi HuoXueFang on Expressions of Serological Indexes Associated to Vulnerable Plaque of Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2012,25(04):1.
[6]王凯,林文.丹红与丹参酮ⅡA治疗冠心病心绞痛疗效比较[J].西部中医药,2013,26(08):88.
 WANG Kai,LIN Wen.Comparison between DanHong Injection and Tanshinone ⅡA in Treating Angina Pectoris of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):88.
[7]刘超,李成山,李妍怡△.中风膏对缺血性脑卒中患者血小板聚集率的影响[J].西部中医药,2013,26(12):5.
 LIU Chao,LI Chengshan,LI Yanyi.Effects of ZhongFeng Ointment on Platelet Aggregation Rate of the Patients with Ischemic Stroke[J].Western Journal of Traditional Chinese Medicine,2013,26(04):5.
[8]孙涛,朱成朔.通冠丸治疗不稳定型心绞痛40例[J].西部中医药,2013,26(12):73.
 SUN Tao,ZHU ChengShuo.TongGuan Wan for 40 Cases of Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2013,26(04):73.
[9]王万兰,苏昶才,熊新荣.丹红注射液联合硝酸酯类药物治疗冠心病心绞痛[J].西部中医药,2013,26(12):93.
 WANG Wanlan,SU Changcai,XIONG Xinrong.DanHong Injection Combined with Nitrates in Treating Angina Pectoris of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):93.
[10]崔巧玲,贾喜平,郑强霞,等.缺血性脑中风患者预防压疮的舒适护理研究[J].西部中医药,2014,27(01):126.
 CUI Qiaoling,JIA Xiping,ZHENG Qiangxia,et al.Research on Comfort Care for Preventing Pressure Sore of the Patients Suffering from Ischemic Stroke[J].Western Journal of Traditional Chinese Medicine,2014,27(04):126.

备注/Memo

备注/Memo:
吴中兴(1972—),男,副主任医师。研究方向:心脑病的研究与治疗。四川省卫生和计划生育委员会科研项目(17PJ091)。
更新日期/Last Update: 2022-06-24